Corrigendum to "Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized active-controlled trial" [Vaccine 40(19) (2022) 2705–2713]. Issue 25 (31st May 2022) - Crothers, Jessica W.; Ross Colgate, Elizabeth; Cowan, Kelly J.; Dickson, Dorothy M.; Walsh, MaryClaire; Carmolli, Marya; Wright, Peter F.; Norton, Elizabeth B.; Kirkpatrick, Beth D.